Searched for
CHEMOTHERAPY
NEET-UG re-exam answer sheets being evaluated, results soon: NTA SourcesThe National Testing Agency (NTA) has begun the evaluation of answer sheets for the NEET-UG re-examination, with results expected to be dec...- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- NTA dismisses video claiming NEET-UG 2026 paper leak as 'fake', says re-exam successfully heldNEET-UG 2026: The National Testing Agency (NTA) has debunked a viral video claiming a NEET-UG 2026 paper leak, labeling it as fake and emph...
- 22.7 lakh students appear for NEET re-test amid AI, CCTV and biometric vigilThe National Testing Agency (NTA) conducted the NEET-UG re-examination on Sunday for 22.7 lakh candidates at 5,440 centres in India and 14 ...
- NEET re-exam went well; we are 100 per cent confident: NTA Director GeneralMore than 20 lakh candidates appeared for the NEET (UG) 2026 re-examination on June 21 across 5,440 centres in India and 14 centres abroad....
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Should you buy OPD cover in health insurance? Over 40% of healthcare costs are paid out-of-pocket in IndiaOPD cover in health insurance addresses out-of-pocket expenses for doctor visits, diagnostics, and medicines without hospitalization. While...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- 2-hour hospitalisation: What health insurance policies really cover and what they excludeNew health plans cover treatments requiring two hours of hospitalisation, but exclusions remain critical.
- She was dancing at an office party. Next day, doctors gave her a shocking diagnosis. Years of treatment, she lost her hair but found a fearless version of herselfAnvita Kamath, diagnosed with breast cancer at 28, faced a grueling treatment after discovering the disease had spread to her lymph nodes. ...
- The ticking price tag: What delaying parenthood really costs you financially and biologicallyA growing number of couples are choosing to delay parenthood in pursuit of career milestones, financial stability, and personal goals. But ...
- Less than 24 hours in Hospital? Know about health insurance coverage for day care treatments, surgeries, and emergency proceduresMany policyholders believe health insurance claims require a 24-hour hospital stay. However, modern policies cover numerous treatments comp...
- HCG opens new Bengaluru facility with Rs 129 crore investmentHealthCare Global Enterprises (HCG) has inaugurated a new 132-bed oncology facility in Bengaluru, marking its third hospital in the city wi...
- 'Raaj Kumar was moody': Actor called everyone 'Jaani' after his dog's name. Director draws comparison between him and Amitabh BachchanFilmmaker KC Bokadia revealed that working with veteran actor Raaj Kumar was more challenging than working with Amitabh Bachchan. Raaj Kuma...
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
Load More
